Specialty Pharmacy

Clinical education, strong data analytics, and valuing collaboration are the best ways to provide patient support and access to specialty pharmaceutical manufacturers.

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.

Study shows the recurrence rate was within the expected range for breast cancer survivors receiving spironolactone and those who did not.

The COVID-19 pandemic has contributed to specialty pharmacy outpacing traditional pharmacy in non-discounted spending.

Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.

During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.

Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.

Although working from home created challenges for contacting stakeholders, some companies saw higher accuracy and fewer sick days among employees.

A new test may help direct treatments for patients with rare breast cancer mutations.

A discussion at NASP 2020 looked at how pharmacy graduates can get a start in the specialty pharmacy field.

When treating these diseases, immunoglobulin is effective because of its ability to be used by the immune system to neutralize pathogens, such as pathogenic bacteria, fungi, and viruses.

Having a certified specialty pharmacist (CSP) credential can help applicants get hired and be more impactful in the specialty pharmacy arena.

The CINtec PLUS Cytology assay is indicated for women who undergo cervical cancer screening and test positive for high-risk types of human papillomavirus.

It makes the most sense to get more technicians involved when pharmacies are continuing to grow, since the number of roles that are needed to operate are well suited for technicians, said Jonathan Ogurchak, PharmD, CSP.

National Association of Specialty Pharmacy gives out annual awards during virtual conference.

Because regular SMS messaging is not fully HIPAA-compliant, one solution may be to initiate contact via a text that links to an online platform.

The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.

Buffalo Bills Hall of Fame quarterback Jim Kelly shared with specialty pharmacists his story of perseverance, tincluding his fight against squamous cell carcinoma in his upper jaw.

Following the global impact of COVID-19 on the health care system in 2020, there have been some clear changes in HIV care in the United States.

The growth of telehealth, ongoing prescriber verification challenges, and the need for a universal patient identifier are all key issues that have arisen for pharmacists during the COVID-19 pandemic.

Magrolimab is a first-in-class, investigational anti-CD47 monoclonal antibody used in combination with azacitidine in treatment-naïve patients with high and very high-risk myelodysplastic syndrome,

Understanding the role of abemaciclib (Verzenio) in managing patients with hormone receptor positive and human epidermal growth factor receptor 2 negative metastatic breast cancer is crucial.

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.

Amid rising cancer care costs, a focus on chemotherapy stewardship may result in cost savings, according to a session of the HOPA Practice Management 2020 Virtual Learning Event.

The Mediterranean diet has shown efficacy in preventing several noncommunicable diseases.

An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.

The FDA grants fast track designation to the highly-selective N-terminal domain inhibitor EPI-7386 for the treatment of adult patients with metastatic castration-resistant prostate cancer.

Bristol Myers Squibb announced it will present data from research spanning 15 different cancers with high unmet need at the ESMO Virtual Congress 2020.

Figuring out how to target vulnerable cells in breast cancer tumors can help treat the disease more effectively.